RxDoctor Payments Data

Jennifer Pharris, DO

Family Medicine · Wichita, KSNPI 1508020165

Payments from drug & device makers

$999in general payments, 2019–2025

Across 57 payments — averaging $17.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$230
  • Pfizer$213
  • Novo Nordisk$207
  • Abbott$83
  • AbbVie$69
  • Inspire Medical Systems, Inc.$29
  • plus $167 from 9 others

What the payments were for

  • Food & beverage$999100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$999 in reported general payments places this provider in the 60th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$30,954
Medicare patients
95
Services billed
391

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide44$57,351
JardianceEmpagliflozin58$56,942
LinzessLinaclotide39$36,843
EliquisApixaban35$36,221
MounjaroTirzepatide17$19,199
TrulicityDulaglutide15$18,349
RexultiBrexpiprazole11$16,223
Tresiba Flextouch U-100Insulin Degludec21$13,043
Trelegy ElliptaFluticasone/Umeclidin/Vilanter19$12,600
MyrbetriqMirabegron13$11,286
Breo ElliptaFluticasone/Vilanterol18$8,729
FarxigaDapagliflozin Propanediol13$7,441
BelsomraSuvorexant12$5,490
TrintellixVortioxetine Hydrobromide11$5,422
Pregabalin52$4,116

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$207$57,35144 claims
Boehringer IngelheimJardiance$27$56,94258 claims
AbbVieLinzess, Synthroid$69$38,05455 claims
Lilly USA, LLCMounjaro, Trulicity$28$37,54832 claims
PfizerEliquis$213$36,22135 claims
GSKTrelegy Ellipta, Breo Ellipta, Shingrix$17$25,09454 claims
Otsuka America Pharmaceutical, Inc.Rexulti$16$16,22311 claims
Astellas Pharma US IncMyrbetriq$23$11,28613 claims
AstraZenecaFarxiga, Symbicort$230$10,03924 claims
MerckBelsomra$13$5,49012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in Wichita

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →